This audit aims to ensure that the budget invested in the NHS D&G Joint Formulary calcium channel blockers (CCBs) for the management of hypertension and angina is cost effective and rational.
The aim of this audit is to review patients diagnosed with hypertension in the past 6 months to ensure treatment is prescribed as per the NICE clinical guideline 127.
The aim of this audit is to review steroid prescribing in patients with a diagnosis of PMR and highlight patients who require review of side-effects, patient on higher doses for a significant period without step-down, lack of co-prescription for bone protecting agents or gastrointestinal protection, or patients who have been taking oral or IM steroids for greater than three years.